Fagron Shareholders Approve Key Resolutions at AGM

Author: Evelyn Baker Updated: 05-12-2025 01:16 PM

Fagron Shareholders Approve Key Resolutions at AGM

Fagron, a leading entity in the realm of pharmaceutical compounding, conducted its annual general meeting with great success where all proposed resolutions received the nod from its shareholders. This meeting marks a significant moment for Fagron as it seeks to further enhance its operations and uphold its commitment to personalized medicine.

Key Resolutions Approved

Among the important decisions taken during the meeting were the endorsement of Fagron's annual financial statements and a proposal for a dividend of €0.35 per share pertaining to the fiscal year 2024. Additionally, the remuneration policy was solidified, alongside the ratification of the statutory auditor for the years spanning from 2025 to 2027. A notable highlight was the reappointment of Ann Desender BV as an independent non-executive director, a role she will continue to hold until the annual meeting in 2029.

Comprehensive Meeting Documentation

All pertinent documents related to the meetings have been uploaded on Fagron’s official website, ensuring transparency and accessibility for all shareholders. The minutes of the meetings will also be made available online for review.

Dividend Calendar Information

The board outlined a clear schedule concerning the dividend payments to keep shareholders well-informed:

Ex-dividend date: 19 May 2025
Record date: 20 May 2025
Payment date: 21 May 2025

Further Information for Investors

For additional inquiries, stakeholders are invited to reach out via email for more information on business operations and investment opportunities. Fagron is dedicated to maintaining open lines of communication with its investors.

About Fagron

Fagron stands out as a major player in pharmaceutical compounding on a global scale, focusing on personalized medicine. With operations in over 30 countries, Fagron delivers tailored medicinal solutions to hospitals, pharmacies, and clinics, ensuring that patient needs are met with precision and care.

Based in Belgium, Fagron NV is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. The Dutch entity, Fagron BV, manages the operational arms of the company from its headquarters in Rotterdam, underscoring Fagron's strong European presence in the market.

Frequently Asked Questions

What major resolutions did Fagron shareholders approve?

Shareholders approved the annual financial statements, a dividend proposal, remuneration policy, and auditor appointments.

When is the payment date for Fagron's dividend?

The payment date for the approved dividend is scheduled for May 21, 2025.

How does Fagron ensure shareholder communication?

Fagron maintains transparency by providing meeting documents and minutes on their website and encouraging direct communication through email.

What is Fagron's main business focus?

Fagron specializes in pharmaceutical compounding, primarily providing personalized medicine to healthcare facilities across multiple countries.

Where is Fagron's headquarters located?

Fagron NV is headquartered in Nazareth, Belgium, with operational management conducted by Fagron BV based in Rotterdam, the Netherlands.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Fagron Shareholders Approve Key Resolutions at AGM